A study of 6,298 patients undergoing primary angioplasty for ST-segment elevation myocardial infarction found those with diabetes had higher rates of reinfarction, stent thrombosis, target vessel revascularization and death than those who did not have diabetes. The results were published in Diabetes Care.
Diabetes raises death risk in STEMI patients undergoing angioplasty
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||